首页> 外文会议>Annual Meeting of the Japanese Society for Dialysis Therapy.;International Society of Blood Purification., Congress. >What Is the Best Dialysis Therapy in Developed and Developing Countries? Peritoneal Dialysis and/or Hemodialysis: The Trend in Korea
【24h】

What Is the Best Dialysis Therapy in Developed and Developing Countries? Peritoneal Dialysis and/or Hemodialysis: The Trend in Korea

机译:发达国家和发展中国家最好的透析治疗是什么? 腹膜透析和/或血液透析:韩国的趋势

获取原文

摘要

In Korea, peritoneal dialysis (PD) penetration peaked around 2005 at 23%, after which it declined and has remained at 10.5%. Two factors possibly explain the decrease: more favorable physician incentives to perform hemodialysis (HD) and disincentives for private clinics to perform PD, even though they account for a large percentage of dialysis centers in Korea. Early referral to nephrolo-gists has been shown to be associated with better survival and lower medical costs than late referral, highlighting a possible role for systemic intervention to encourage early referrals. This benefits patients by allowing adequate time for dialysis modality selection, relevant training, and preparation for dialysis. In cohorts enrolled from 2005 to 2008, HD showed better survival than PD in patients aged 55 and over. However, PD survival increased more sharply than HD survival over the past decade, a phenomenon particularly significant in diabetic patients and/or patients aged 65 and over. In a prospective study of a cohort enrolled since 2009, PD was associated with better survival than HD, particularly in the early period of dialysis. The survival advantage was shown to last about 3.5 years, with a particularly strong benefit in men or patients under 65. Given the average wait time of 5 years for deceased-donor kidney transplantation (KT) in Korea, PD might be preferably considered for young patients on the wait list. Two critical developments to monitor in PD patients are early death from pneumonia and high risk of acute myocardial infarction. Selection of a dialysis modality that delivers the greatest possible benefit to individual patients should consider age, diabetes status, and KT donor availability.
机译:在韩国,腹膜透析(PD)渗透率在2005年达到23%左右达到峰值,之后它下降并保持在10.5%。两个因素可能解释了减少:更有利的医生激励措施,以进行血液透析(HD)和禁用私人诊所的抑制,即使他们占韩国的大量透析中心。早期转诊到肾脏 - GIST的早期转诊已被证明与更好的生存和较低的医疗成本相关,而不是晚期推荐,突出了系统干预的可能作用,以鼓励早期推荐。这是通过允许透析模态选择,相关培训和透析的准备时间来患者患者。在从2005年到2008年招收的群组中,HD在55岁及以上的患者中表现出比PD更好的存活率。然而,在过去十年中,Pd存活率比HD生存率更大,糖尿病患者和/或65岁甚至超过65岁的患者特别重要的现象。在征收自2009年以来的群组的前瞻性研究中,PD与HD的更好的存活相关,特别是在透析的早期。持续的生存优势持续约3.5岁,在65岁以下的男性或患者中具有特别强烈的益处。鉴于韩国的死者供体肾移植(KT)的平均等待时间,PD可能优选考虑年轻等候名单上的患者。在PD患者中监测的两项关键发展是肺炎的早期死亡,急性心肌梗死的高风险。选择透析形式,为个体患者提供最大可能的益处,应考虑年龄,糖尿病状态和KT捐赠者可用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号